1. Ambient particulate matter attenuates Sirtuin1 and augments SREBP1-PIR axis to induce human pulmonary fibroblast inflammation: molecular mechanism of microenvironment associated with COPD
   Chia-Ping Tien et al, 2019, Aging CrossRef
2. Recent advances in the management of diabetic retinopathy
   Nabeela Dulull et al, 2019, Drug Discovery Today CrossRef
3. Melatonin protects retinal tissue damage in streptozotocin-induced aged rats
   Adem Atacak et al, 2023, Archives of Gerontology and Geriatrics CrossRef
4. Lipids and Diabetic Retinopathy
   Alicia J. Jenkins, 2023, Lipoproteins in Diabetes Mellitus CrossRef
5. Sirtuin 1 as the mechanism of action of agents used in the diabetes mellitus pharmacotherapy
   Agnieszka Stelmaszyk et al, 2021, European Journal of Pharmacology CrossRef
6. SIRT1: a promising therapeutic target in type 2 diabetes mellitus
   Ainaz Mihanfar et al, 2024, Archives of Physiology and Biochemistry CrossRef
7. Metabolic Memory in Diabetes – Mechanistic Insights and the Impact of Cardiovascular Medication
   Raluca Sosdean et al, 2021, Romanian Journal of Cardiology CrossRef
8. Astragalus polysaccharides suppresses high glucose-induced metabolic memory in retinal pigment epithelial cells through inhibiting mitochondrial dysfunction-induced apoptosis by regulating miR-195
   Ping Liu et al, 2019, Molecular Medicine CrossRef
9. Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis
   Ali Mahmoudi et al, 2021, BioMed Research International CrossRef
10. Oxidative Stress‐Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy
    Cheng Li et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
11. The role of SIRT1 in diabetic retinopathy
    Hedyieh Karbasforooshan et al, 2018, Biomedicine & Pharmacotherapy CrossRef
12. Metabolic memory in mitochondrial oxidative damage triggers diabetic retinopathy
    Zhaoge Wang et al, 2018, BMC Ophthalmology CrossRef
13. Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies
    Alicia J. Jenkins et al, 2022, Diabetologia CrossRef
14. Fenofibrate Exerts Protective Effects in Diabetic Retinopathy via Inhibition of the ANGPTL3 Pathway
    Na Wang et al, 2018, Investigative Opthalmology & Visual Science CrossRef
15. Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives
    Alexander Berezin, 2016, Diabetes & Metabolic Syndrome: Clinical Research & Reviews CrossRef
16. Ischemic Retinopathies: Oxidative Stress and Inflammation
    José Carlos Rivera et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
17. SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication
    Teng Meng et al, 2020, Frontiers in Endocrinology CrossRef
18. Epigenetic control of gene regulation during development and disease: A view from the retina
    Ximena Corso-Díaz et al, 2018, Progress in Retinal and Eye Research CrossRef
19. Role of Sirtuin 1 in the pathogenesis of ocular disease (Review)
    Mengwen Zhou et al, 2018, International Journal of Molecular Medicine CrossRef
20. Resveratrol inhibits high-glucose-induced inflammatory “metabolic memory” in human retinal vascular endothelial cells through SIRT1-dependent signaling
    Tingting Jiang et al, 2019, Canadian Journal of Physiology and Pharmacology CrossRef
21. Diabetic retinopathy, oxidative stress, and sirtuins: an in depth look in enzymatic patterns and new therapeutic horizons
    Marcella Nebbioso et al, 2022, Survey of Ophthalmology CrossRef
22. Fenofibrate Ameliorates Oxidative Stress-Induced Retinal Microvascular Dysfunction in Diabetic Rats
    Jun Li et al, 2018, Current Eye Research CrossRef
23. Fenofibrate inhibits hypoxia‐inducible factor‐1 alpha and carbonic anhydrase expression through activation of AMP‐activated protein kinase/HO‐1/Sirt1 pathway in glioblastoma cells
    Chingju Lin et al, 2021, Environmental Toxicology CrossRef